Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease
A clinical trial update evaluating the use of real-time tissue elastography to assess liver fibrosis in chronic liver disease, including chr…
-
CLINICAL_TRIALS research · 2011-05-25Clinical Trial Update: The Metabolic Profile and Adipocytokine Alterations of Patients With HCV Infection Before and After HCV Therapy
This clinical trial update investigates metabolic profile and adipocytokine changes in patients with hepatitis C before and after HCV therap…
-
CLINICAL_TRIALS research · 2011-05-24Clinical Trial Update: Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease [NA]
A clinical trial comparing CT screening versus ultrasound for liver cancer in patients with advanced liver disease (cirrhosis, end-stage liv…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: MMF Influence on HCV Viral Evolution After Liver Transplantation
A completed Mayo Clinic-sponsored clinical trial studied how mycophenolate mofetil (MMF) affects hepatitis C virus evolution in liver transp…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: TMC435350-TiDP16-C101 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of Increasing Oral Doses of TMC435350 After Single and Repeated Dosing [Phase 1]
A Phase 1 study evaluating safety, tolerability and pharmacokinetics of increasing oral doses of TMC435350 after single and repeated dosing …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection [Phase 2]
Phase 2 clinical trial investigating coinfection of Hepatitis C and HIV has completed. Anemia is listed among the study conditions.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study to Evaluate the Erythropoietic Response in Hepatitis C Virus (HCV) Patients Receiving Combination Ribavirin (RBV)/Interferon (IFN) Therapy or RBV/PEG IFN (NATURAL HISTORY-HCV) [Phase 2]
Phase 2 study evaluating erythropoietic response in hepatitis C patients treated with ribavirin plus interferon or ribavirin plus pegylated …
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C [Phase 4]
An open-label Phase 4 study evaluated the safety and pharmacokinetics of nelfinavir in subjects with HIV infection and Hepatitis C. The tria…
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects [Phase 1]
Pfizer completed a Phase 1 study of CPG10101 in relapsed hepatitis C patients, reporting safety and early signals of efficacy.
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients? [NA]
A clinical trial update examining whether vitamin D supplementation improves sustained virologic response in genotype 2 and 3 chronic hepati…
-
CLINICAL_TRIALS research · 2011-04-28Clinical Trial Update: Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients? [NA]
This clinical trial update examines whether 3 months of vitamin D plus pegylated interferon and ribavirin improves sustained virologic respo…
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) [Phase 2]
Phase 2 trial evaluating pegylated interferon alfa-2a as maintenance therapy and its effect on liver disease progression in people co-infect…
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b
A clinical trial update reports that chronic hepatitis C genotype 1a shows a better virological response to antiviral therapy than genotype …
-
CLINICAL_TRIALS trial_result · 2011-04-21Clinical Trial Update: Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413)
Clinical trial update reporting results on whether patient support from medical staff improves adherence to PegIntron (peginterferon alfa-2b…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol) [Phase 1]
A Phase 1 trial assessed whether steady-state filibuvir alters the pharmacokinetics of oral contraceptives levonorgestrel and ethinyl estrad…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085) [Phase 3]
This document provides a Phase 3 trial update on pegylated interferon alfa-2b in patients with hepatitis C-related cirrhosis and high liver …
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Australian Trial in Acute Hepatitis C [Phase 4]
An update on a Phase 4 Australian clinical trial for acute Hepatitis C, which has completed.
-
CLINICAL_TRIALS research · 2011-04-06Clinical Trial Update: Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment
A clinical trial update examining reinfection rates and long-term outcomes after Hepatitis C treatment in people who inject drugs.
-
CLINICAL_TRIALS research · 2011-04-04Clinical Trial Update: Y- Shaped Pegylated Interferon (YPEG-IFNα-2a) Plus Ribavirin in Egyptian Patients With Untreated Chronic Hepatitis C [Phase 2, Phase 3]
Clinical trial update describes a Phase 2/3 study of Y-shaped Pegylated Interferon alpha-2a plus Ribavirin for untreated chronic Hepatitis C…
-
CLINICAL_TRIALS trial_result · 2011-03-30Clinical Trial Update: Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients [Phase 2]
Phase 2 trial assessing efficacy and safety of escitalopram for preventing depression induced by peg-interferon in Hepatitis C patients; stu…
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144)(COMPLETED) [Phase 4]
Phase 4 trial comparing non-extended versus 24-week extended Peg-Intron (pegylated interferon alfa-2b) with ribavirin in genotype 1 chronic …
-
CLINICAL_TRIALS withdrawal · 2011-03-15Clinical Trial Update: A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype I [Phase 2]
This is a Phase 2 clinical trial update indicating withdrawal of a study evaluating BMS-824393 in combination with peginterferon alfa-2a and…
-
CLINICAL_TRIALS trial_result · 2011-03-11Clinical Trial Update: Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders [Phase 2, Phase 3]
A completed Phase 2/3 trial update assessing subcutaneous continuous infusion of Interferon alfa-2b with Ribavirin in genotype 1 chronic hep…
-
CLINICAL_TRIALS trial_result · 2011-03-09Clinical Trial Update: Study of VX-985 in Subjects With Chronic Hepatitis C [Phase 1]
This clinical trial update reports completion of a Phase 1 study evaluating VX-985 in subjects with chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED) [Phase 3]
A Phase 3 study (P05016) comparing 24 weeks versus 48 weeks of Peginterferon alfa-2b plus ribavirin in treatment-naïve chronic hepatitis C (…